Spero Therapeutics
Price & Volume
Stats
See more52W Range | $1.01-$1.89 |
Market Cap | $58.3M |
Shares Short | 493,832 |
Financials
See moreRevenue (12 Mos) | $118.4M |
Revenue Growth (YoY) | 275.4% |
Gross Profit (12 Mos) | -$42.1M |
Diluted EPS | $0.08 |
News
See moreYahoo Finance • last year
SHAREHOLDER ALERT: Levi & Korsinsky, LLP Notifies Shareholders of an Investigation Concerning Possible Breaches of Fiduciary Duty by Certain Officers and Directors of Spero Therapeutics Inc. (NASDAQ: SPRO)
Yahoo Finance • last year
Spero Therapeutics to Provide Business Update and Report Third Quarter 2023 Financial Results on Monday, November 13, 2023
Yahoo Finance • last year
Spero Therapeutics to Present at Upcoming November Investor Conferences
Yahoo Finance • last year
Spero Therapeutics Appoints Esther Rajavelu as Chief Financial Officer and Chief Business Officer
About
CEO | Mr. Satyavrat Shukla C.F.A. |
CFO | Ms. Esther P. Rajavelu |
Address | 675 Massachusetts Avenue, Cambridge, MA, United States, 02139 |
Sector | Healthcare |
Industry | Biotechnology |
Full-Time Employees | 46 |
